579-B TIGIT and PD-L1 co-blockade promotes clonal expansion of non-exhausted anti-tumour CD8+ T cells by facilitating costimulation

579-B TIGIT and PD-L1 co-blockade promotes clonal expansion of non-exhausted anti-tumour CD8+ T cells by facilitating costimulation

Bibliographic Details
Main Authors:	Yan Qu, Ira Mellman, Ellen Duong, Thomas D Wu, Eugene Y Chiang, Katherine Nutsch, Karl L Banta, Charles W Tran, Stephanie Mittman, Barzin Y Nabet, Namrata S Patil
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

527 Clonal hematopoiesis is associated with reduced response to immune checkpoint inhibitors in lung cancer
by: Ira Mellman, et al.
Published: (2023-11-01)

Costimulation blockade: current perspectives and implications for therapy.
by: Kinnear, G, et al.
Published: (2013)

Costimulation blockade and Tregs in solid organ transplantation
by: Moritz Muckenhuber, et al.
Published: (2022-09-01)

579-C Reinvigoration of progenitor-exhausted CD8 T cells by anti-CTLA-4 contributes to the sustained activity of combination checkpoint blockade
by: Xiaowei Xu, et al.
Published: (2023-11-01)

Defective fasL reveals immunregulation after costimulation blockade.
by: Cobbold, S
Published: (2001)

T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis
by: Gonçalo Boleto, et al.
Published: (2018-08-01)

TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
by: Friedrich Haag, et al.
Published: (2022-12-01)

Modeling costimulation.
Published: (2000)

Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity
by: Chun Jing Wang, et al.
Published: (2022-11-01)

Linked sensitization by memory CD4+ T cells prevents costimulation blockade–induced transplantation tolerance
by: Michael S. Andrade, et al.
Published: (2022-06-01)

A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers
by: Negar Hosseinkhani, et al.
Published: (2021-09-01)

Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer
by: Hui Peng, et al.
Published: (2022-12-01)

Author Correction: Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity
by: Chun Jing Wang, et al.
Published: (2023-09-01)

New look at an old costimulator.
by: Linsley, P
Published: (2005)

Costimulation: building an immunological synapse.
by: Dustin, M, et al.
Published: (1999)

Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
by: Spriewald, B, et al.
Published: (2008)

P579: Gene variant spectrum in patients with familial exudative vitreoretinopathy
by: Sarah van der Ende, et al.
Published: (2023-01-01)

579 Evaluation of cemiplimab treatment duration: clinical outcomes in advanced CSCC
by: Francesca Sparano, et al.
Published: (2023-11-01)

The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients
by: Anna Pawłowska, et al.
Published: (2022-11-01)

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma
by: Sophie Rovers, et al.
Published: (2022-03-01)

High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor Responses
by: Hampartsoum B. Barsoumian, et al.
Published: (2022-01-01)

Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML
by: Franziska Brauneck, et al.
Published: (2021-11-01)

Novel costimulators in the immune gene therapy of cancer.
by: Galea-Lauri, J, et al.
Published: (1996)

TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.
by: Glen M Chew, et al.
Published: (2016-01-01)

Blocking TIGIT/CD155 signalling reverses CD8+ T cell exhaustion and enhances the antitumor activity in cervical cancer
by: Lu Liu, et al.
Published: (2022-06-01)

Inducible T-Cell Costimulator Ligand Plays a Dual Role in Melanoma Metastasis upon Binding to Osteopontin or Inducible T-Cell Costimulator
by: Davide Raineri, et al.
Published: (2021-12-01)

Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta
by: Nikolai Siebert, et al.
Published: (2023-06-01)

Irreversible electroporation for treating pancreatic cancer: Interventional procedures guidance [IPG579]
by: Powell, J, et al.
Published: (2017)

Ubiquitination role in TCR signaling and costimulation via GITR
by: Muller, J, et al.
Published: (2016)

On the role of receptor downregulation and costimulation in shaping the T cell response
by: Kruger, P
Published: (2018)

Immune responses in the absence of costimulation: viruses know the trick.
by: Bachmann, M, et al.
Published: (1998)

Costimulation and endogenous MHC ligands contribute to T cell recognition.
by: Wülfing, C, et al.
Published: (2002)

Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade Augments Human T cell Adoptive Cell Transfer
by: Marina Martinez, et al.
Published: (2021-01-01)

Role of Toll-like receptors in costimulating cytotoxic T cell responses.
by: Schwarz, K, et al.
Published: (2003)

A theoretical framework for quantitative analysis of the molecular basis of costimulation.
by: Jansson, A, et al.
Published: (2005)

Photochemistry and Photophysics of Cholesta-5,7,9(11)-trien-3β-ol in Ethanol
by: Jack Saltiel, et al.
Published: (2023-05-01)

Predictive Factors of Recurrence in Patients with Differentiated Thyroid Carcinoma: A Retrospective Analysis on 579 Patients
by: Fabio Medas, et al.
Published: (2019-08-01)

ImmunoPET imaging of TIGIT in the glioma microenvironment
by: Sarah R. Vincze, et al.
Published: (2024-03-01)

TIGIT in Lung Cancer: Potential Theranostic Implications
by: Carlo Pescia, et al.
Published: (2023-04-01)

The landscape of TIGIT target and clinical application in diseases
by: Shu Rui, et al.
Published: (2022-09-01)